|
@MondayNightIBD LIVE: Addressing the Cases That Challenge Your Practice
Statement of Need
Gastroenterologists are trailblazers in health care social media, and #MondayNightIBD (#MNIBD) has harnessed that energy to establish gastroenterologists as not just social media influencers but as clinical practice influencers as well. #MNIBD is not just a weekly social media conversation - it is an international platform that is moving the field forward by crowdsourcing the expertise of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients ... |
|
|
Improving the Quality of Care for Patients with Atopic Dermatitis: Integrating Measurement-Based Tools Into Your Clinical Practice
Statement of Need
Attitudes about atopic dermatitis are evolving with the emergence of new and effective treatments. With the average dermatologist having not enjoyed caring for patients with AD for decades, there is little to no consensus in current practice about validated tools to assess and monitor the severity of the diseases and no consistent use of diagnostic or assessment tools. This lack of knowledge and education leads to confusion, poor recognition, and absence of assessment of AD ... |
|
|
Navigating the New Psoriasis Guidelines: Implications for Clinical Practice
Statement of Need:
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have recently released new joint guidelines that outline best practices for the management of psoriasis (PsO) with biologics, the need for awareness and attention to comorbidities, and guidelines for pediatric PsO treatment. Clinicians must ensure that they are aware of these guidelines and of strategies to incorporate them into clinical practice, including the integration of biologic ther... |
|
|
At-Risk Patients Hidden in Plain Sight: Real-World Strategies for Screening and Treating Hepatitis B Virus
Statement of Need
Chronic hepatitis B virus (HBV) remains a global epidemic, resulting in significant morbidity and mortality. In 2015, there were 257 million people worldwide infected with HBV. In 2016, only 10.5% were diagnosed, with only 16.7% receiving treatment, and without intervention, there are 19 million deaths anticipated by the end of 2020. These numbers are startling as they exist despite the availability of effective treatment, and this is in part due to lack of clinician knowl... |
|
|
A Deeper Dive into NASH Diagnosis and Treatment: An Augmented Reality Experience
Statement of Need
Obesity and diabetes are on the rise, leading to an increased prevalence of non-alcoholic fatty liver disease (NAFLD), which in some cases may progress to non-alcoholic steatohepatitis (NASH). NAFLD effects approximately 30% of the U.S. population, with NASH effecting about 5%. NASH comes with a significant risk of progression to advanced liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Disease models project that the number of individuals with end-stage live... |
|
|
What the Future Holds for NASH: An Augmented Reality Look into Disease Stating and Targeted Therapies
Statement of Need
Given the rising prevalence of non-alcoholic fatty liver disease (NAFLD) and the societal and economic burden of its aggressive subtype, non-alcoholic steatohepatitis (NASH), it is important that hepatologists and gastroenterologists are equipped with the latest tools to diagnose NASH. While there are currently no approved therapies for the treatment of NASH, several targeted therapies are being investigated in clinical trials, with high probability of being approved in the ... |
|
Opioid Overdose Risk and Prevention
This is a 5 minute online activity included in the READINESS Opioid Learning Center "library".
This activity provides important information on opioid overdose – risks involved, prevention strategies & tips, and more to help you better understand how to combat opioid overdose and be better prepared in the event of an opioid overdose.
READINESS develops and hosts custom opioid eLearning centers for health systems, pharmacies, and organizations to support opioid stewardship and education ... |
|
|
How to Use Narcan (naloxone) Nasal Spray
This is a 5 minute online activity included in the READINESS Opioid Learning Center "library".
This activity provides important information on Narcan (naloxone) nasal spray – how to administer the medication, proper technique, and more to help you better understand how to use Narcan (naloxone) nasal spray.
READINESS develops and hosts custom opioid eLearning centers for health systems, pharmacies, and organizations to support opioid stewardship and education initiatives. Offer your com... |
|
|
Support Your Community with an Opioid eLearning Center Hosted by READINESS
READINESS develops and hosts custom opioid eLearning centers for health systems, pharmacies, and organizations to support opioid stewardship and education initiatives. Offer your community an intuitive and accessible eLearning center to support opioid education and awareness.
|
|
|
Don’t Snooze on the Latest Evidence on Excessive Daytime Sleepiness in OSA and Narcolepsy: An Expert-Guided Tour of the Sleep 2019 Annual Meeting
Residual excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) and narcolepsy is a common, debilitating condition that compromises patients' overall health, wellness, and safety. The field of sleep medicine is rapidly evolving to address the unmet needs of EDS as novel treatment options become available.
In this CME Outfitters dynamic, interactive infographic, expert faculty discuss the impact of EDS on daily functioning, highlight the efficacy of current and nov... |
|
|
Zooming In on the Education and Empowerment of Patients in AMD Care
FDA-approved agents that target vascular endothelial growth factor (VEGF) constitute important elements of optimal management of AMD. Prior authorization (PA) requirements limit patient access to these therapies. Navigating the PA process can be frustrating for patients, and may result in treatment abandonment leading to suboptimal outcomes. Hence, there is a need for patients to become advocates of their treatment choice.
The final module of this CME Outfitters Snack series describes step ... |
|
|
Recent Clinical Trial Data on the Safety and Efficacy of Current and Emerging Therapies to Optimize Schizophrenia Management
Safe and effective treatments for schizophrenia are imperative to optimizing personalized therapy, which helps in reducing relapse and promoting functional recovery in patients with schizophrenia. Emerging data on reducing symptoms, maintaining effective therapy over long-term periods, and minimizing treatment-related metabolic side effects can guide clinicians in choosing the best therapies for their patients. In the final episode of the CMEOcast podcast series on schizophrenia, expert facult... |
|
|
Navigating Through the Latest Advances in Monoclonal Antibodies: Translating Evidence to the Care of Patients with Psoriasis
Recent years have seen an increase in the number of therapeutic monoclonal antibodies (mAbs) that are available to treat a variety of conditions caused by immune-mediated chronic inflammation such as psoriasis. Health care professionals are often presented with complex and conflicting information surrounding concepts of mAb production and immunogenicity; therefore, there is a significant need for education in this area, especially as distinguishing the relative clinical efficacy and safety pro... |
|
|
Minimizing the Burden of Prior Authorization in AMD Through Actionable Strategies and Improved Communication
The development of anti–vascular endothelial growth factor (VEGF) agents has revolutionized the treatment of age-related macular degeneration (AMD). Nevertheless, optimal management of AMD is impeded by challenges in access to FDA-approved therapies. Step therapy, a type of prior authorization (PA) instituted by the payer, mandates that more cost-effective therapies be used before more expensive alternatives, in a stepwise approach. However, applying this strategy to vision-threatening disea... |
|
|
Long-Acting Injectables for Schizophrenia: An Effective, Yet Often Underutilized Tool for Rapid Symptom Reduction and Restoration of Function
Schizophrenia is a serious and debilitating disorder that often poses a considerable challenge to clinicians. While long-acting injectables (LAIs) have emerged as a viable means to address patient nonadherence – often a component of schizophrenia management – clinicians often fail to implement the use of LAIs. Many times this is due to clinicians not being aware of updates such as the introduction of LAIs with increased dosing intervals, knowledge that is an important aspect of narrowing p... |
|
|
Keeping the Patient in the Center in AMD Care
Age-related macular degeneration (AMD) is the leading cause of legal blindness in adults over age 50, but the development of agents that target vascular endothelial growth factor (VEGF) has revolutionized its treatment. There are currently two FDA-approved agents (ranibizumab and aflibercept) and one off-label anti-VEGF agent (bevacizumab) being used to treat patients with AMD, and data from emerging anti-VEGF agents have also demonstrated efficacy in improving visual acuity. However, step the... |
|
|
Honing in on the Appeal Process to Improve Access to Anti-VEGF Therapy for Patients with AMD
Step therapy requirements have limited patient access to FDA-approved, anti–vascular endothelial growth factor (VEGF) agents for the treatment of AMD. Prior authorization requests for these therapies are commonly denied. Hence, it is important that clinicians be aware of the approaches to overcome these barriers and implement systematic and clinically supported appeals that ensure uninterrupted anti-VEGF therapy for patients with AMD.
In the third module of this CME Outfitters Snack seri... |
|
|
Biomarkers for Diagnosis and Prognosis of MS
It is an exciting period for the clinical management of multiple sclerosis (MS), with an expanding treatment landscape and recent approval of new disease-modifying therapies (DMTs) for both relapsing and progressive MS. The Consortium of Multiple Sclerosis Centers (CMSC) 2019 Annual Meeting, the largest MS meeting in North America, features the latest information on cutting-edge research findings, clinical advances in the diagnosis and management of MS, and emerging care issues, as well as new... |
|
|
Current and Emerging Therapies for Schizophrenia: How MOA Affects Clinical Outcomes
Clinical trial data that addresses the safety and efficacy of antipsychotics is continuously emerging, with a focus on optimizing the management of schizophrenia. These data include the identification of strategies with novel mechanisms of action (MOAs) to effectively resolve symptoms and promote recovery while minimizing metabolic effects.
The second episode of this schizophrenia CMEOcast podcast series explores the MOAs of current and emerging therapies for schizophrenia. Expert faculty ... |
|
|
Management of Sickle Cell Disease in the Emergency Department: A Case-Based Discussion
Sickle cell disease (SCD) is a painful disease with many life-threatening complications including acute chest syndrome, infections, severe anemia, and venous thromboembolism. Patients with SCD often present to the ED and hence, it is critical for clinicians in the emergency department (ED) to be educated so that they can promptly assess and treat acute sickle cell pain and evaluate and treat associated complications. While there are some current therapies for SCD, novel therapies are presently... |
|
|
Putting Pressure on Opioid Prescribing: Novel Approaches to Pain Management
Opioids continue to impact all corners of the United States and its communities, a burden that continues to grow at a rapid pace. The current opioid crisis is incredibly challenging for both patients and health care providers (HCPs). There has been a 30% increase in overdoses among men and a 24% increase among women, with all ages affected. While changing these current trends is important, it cannot be accomplished by policy changes alone. There is no one size fits all model for communities to... |
|
|
Clinical Insights on Recent Advances in Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is a leading, fatal, autosomal recessive disorder that affects approximately one in 10,000 live births. Nusinersen was approved as the first targeted therapy for SMA, and since its groundbreaking approval data has been published that demonstrates its efficacy for both infantile- and later-onset SMA populations. Additionally, recent guidelines were published that provide evidence-based recommendations for the diagnosis and management of SMA.
However, despite the... |
|
|
Pharmacy Technician Series: Cultural Competency With Transgender Patients
See webpage |
|
Spanish for Pharmacists
A comprehensive course for pharmacists and pharmacy technicians to learn basic Spanish language skills to improve their patient counseling and communication skills in a pharmacy. Spanish for Pharmacists provides education on pharmacy "one-liners", tips to communicate with Spanish speaking patients, alphabet, punctuation, general vocabulary, numbers, colors, and more! |
|
|
Cardinal Health: The Innovative Delivery Solutions Group | An Overview
This 15-minute (non-accredited / free) activity provides an overview of the various products, services, and career opportunities available with Cardinal Health Innovative Delivery Solutions. The cactivity contains information on pharmacy management, remote order entry, and telepharmacy. As well as insights right from the Talent Acquisition Manager at Cardinal Health IDS. |
|
|
340B Drug Pricing Discount Program | An Overview
This 7-minute (non-accredited) activity provides an overview of the 340B Drug Pricing Discount Program. It is a ten minute, need-to-know overview of this topic for pharmacy students, tech students, and professionals to gain a working knowledge of 340B - who developed the program, which health systems qualify for the program, and how it impacts patients. |
|
|
The Pharmacy Experience | A Comprehensive Overview of the Pharmacy Market
A ten-hour, 68 module course (non-accredited) serving as an introduction to the pharmacy market and perfect for pharmacy students, pharmacy tech students, professionals new to the pharmacy market, and practitioners. The Pharmacy Experience course explores critical need-to-know subjects, practice settings, roles in a pharmacy, services, and pharmacy technology. |
|
|
7-Night Grenada Resort CME - Travel Medicine, Medical Cannabis for Pain Management, Concierge Medicine, Atrial Fibrillation, Osteoporosis, Dyslipidemia
Pink Gin Beach, St George's, Grenada |
|
|
11-Night Cook Islands & Society Islands CME AWAY™ Cruise
Papeete, Tahiti, Society Islands ● Huahine, Society Islands ● Aitutaki, Cook Islands ● Rarotonga, Cook Islands ● Bora Bora, Society Islands ● Taha'a, Society Islands ● Moorea, Society Islands |
|
|
10-Night Galapagos Islands CME AWAY™ Cruise - Family Medicine, Breast Cancer & Orthopedic Surgery
Quito, Ecuador ● Baltra ● Isla Daphne Grande ● Bahia Darwin ● El Barranco ● Seymour Norte ● Santiago Rabida ● Santa Cruz ● San Cristobal ● Punta Pitt ● Gardner Bay ● Punta Suarez ● Estacion Darwin ● Puerto Ayora ● Plazas Sur |
|
|
7-Night Alaska Dawes Glacier CME AWAY™ Cruise - From COPD to Migraines to Arthritis and More! An Interactive CME Program North of 60
Seattle, Washington ● Ketchikan, Alaska ● Endicott Arm ● Juneau, Alaska ● Skagway, Alaska ● Victoria, British Columbia |
|
|
Abdominal Pain, Celiac Disease, Pediatric GI, Emergency Medicine, Dysphagia, Post Nasal Drip and Thyroid Nodules and Eustachian Tube Dysfunction - Australia & New Zealand CME AWAY Cruise
Auckland, New Zealand • Tauranga (Bay Of Plenty), New Zealand • Wellington, New Zealand • Picton, New Zealand • Kaikoura, New Zealand • Akaroa, New Zealand • Dunedin (Port Chalmers), New Zealand • Stewart Island, New Zealand • Hobart (Tasmania), Australia • Melbourne, Australia • Eden, Australia • Sydney, Australia |
|
|
Anticoagulation Reversal for Life-threatening Bleeding: A Case-based Presentation for the Critical Care Team
Target Audience
This activity is designed to meet the educational needs of physicians, physician assistants, nurses, pharmacists, and other healthcare professionals.
Program Overview
Direct oral anticoagulants (DOACs) are lifesaving drugs for many patients, with transformative impact for patients with atrial fibrillation (AF) and thromboembolism, but they are not without risks. Anticoagulant adverse events have presented hurdles for both healthcare providers and patients, with bleedin... |
|
|
11-Night Spain, Portugal & Canary Islands CME AWAY™ Cruise
Southampton, England • Porto (Leixoes), Portugal • Lanzarote, Canary Islands • Tenerife, Canary Islands • Gran Canaria, Canary Islands • Lisbon, Portugal • Vigo, Spain |
|
|
14-Night Scandinavia & St. Petersburg CME AWAY™ Cruise - Palliative Care for Generalists & Updates on Infectious Diseases
Southampton, England ● Copenhagen, Denmark ● Stockholm, Sweden ● Helsinki, Finland ● St. Petersburg, Russia ● Berlin (Warnemunde), Germany ● Aarhus, Denmark |
|
|
10-Night Italy, Croatia & Montenegro CME AWAY™ Cruise - Gout, RA, Fibromyalgia, Lupus, Raynauds, Cannabinoids, Opioid Use Disorder & Other Addictions
Rome (Civitavecchia), Italy ● Corfu, Greece ● Split, Croatia ● Trieste, Italy ● Koper, Slovenia ● Dubrovnik, Croatia ● Kotor, Montenegro ● Naples, Italy |
|
|
7-Night Norwegian Fjords CME AWAY™ Cruise
Southampton, England ● Bergen, Norway ● Alesund, Norway ● Olden, Norway ● Stavanger, Norway |
|
|
10-Night Venice, Turkey & Greek Islands CME AWAY™ Cruise
Venice, Italy ● Katakolon, Greece ● Santorini, Greece ● Ephesus (Kusadasi), Turkey ● Mykonos, Greece ● Athens (Piraeus), Greece ● Chania (Souda), Crete, Greece ● Zakynthos, Greece |
|
|
14-Night Ireland & Iceland CME AWAY™ Cruise
Southampton, England ● St. Peter Port, Channel Island ● Cork (Cobh), Ireland ● Waterford (Dumore East), Ireland ● Dublin, Ireland ● Glasgow (Greenock), Scotland ● Akureyri, Iceland ● Reykjavik, Iceland ● Belfast, Northern Ireland |
|
|
Needs Across the Patient Continuum: The Intersection of Energy and Protein
Symposium highlights held in conjunction with the ASPEN 2020 Nutrition Science and Practice Conference.
The nutritional needs of critically ill patients during hospitalization and after discharge are complex, and the importance of assessing energy expenditure and tailoring nutritional therapies to the individual is increasingly apparent. Although a great deal of study is still needed, accumulating data on the provision of energy and protein continue to inform clinical practice. This activit... |
|
|
Veterinary Compounding Essentials
July 10-11, 2020
VETERINARY COMPOUNDING ESSENTIALS is an accredited 15 hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing.
Upon completion of this program, the participant will be able to:
• Demonstrate knowledge of ani... |
|
|
WEBINAR: A Guide for Pharmacies Negatively Impacted by COVID-19: Financial Relief Tools and New Business Opportunities
This presentation will assist pharmacies in finding much needed funding and financial relief during these emergent times and be able to remain open and appropriately staffed to care for patients. The presentation will detail not only financial tools and products that exist, but also other forms of relief from expenses and debt that are available to pharmacy providers. Finally, the program will also detail new opportunities under various pharmacy practice acts and payor programs, that will allo... |
|
|
Improving Outcomes for the Statin Intolerant Patient
Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.
Program Overview
Despite the fact that cardiovascular outcome studies involving statins have demonstrated significant cardiovascular event reduction among patients at high risk and have led to statins becoming the gold standard in cardiova... |
|
|
Understanding the Microbiome and Gut Microbiota
In this video commentary, Dr. Amy Barto will examine the role of the gut microbiome in initial and recurrent C. difficile infection. She will also discuss risk factors for recurrent infection and will introduce available and emerging approaches to microbial restoration |
|
|
Professional Conduct and Good Moral Character
The pharmacy profession has a long tradition of respect and trust by the general public. As health professionals, it is important that pharmacists maintain the highest standards of honesty, integrity and ethical behavior. Members of the pharmacy profession bear the responsibility to adhere to the professional, ethical, and legal standards prescribed for the practice of pharmacy. A pharmacist has a duty to tell the truth and to act with conviction of conscience. A pharmacist avoids discriminato... |
|
|
Precision Medicine in Immuno-Oncology: The Evolving Role of Current and Emerging Biomarkers
Patient selection remains a major challenge for the field of immuno-oncology, and the role of biomarkers continues to evolve as new data are released and novel targets are identified. In addition, as the therapeutic landscape continues to change with new indications, combination regimens, and novel immuno-oncology agents, the role of biomarkers will continue to evolve. As a result, many oncology clinicians and pathologists have difficulty remaining up to date with the latest data and best prac... |
|
|
Non-Sterile Compounding Hand Sanitizer During COVID-19 Public Health Emergency
During the Public Health Emergency related to COVID-19, there has been a drastic shortage of hand sanitizers for the public. Recently the FDA, USP and State of Massachusetts has provided guidance on how pharmacies can compound hand sanitizer and sell it over the counter while still being in compliance with all applicable laws. This is an unprecedented step that will allow Pharmacists and Pharmacies in Massachusetts to serve the public. Attendees will be able to apply this information to supply... |
|
|
Give it your best shot: Vaccines Recommended for Older Adults
The purpose of this course is to discuss the required vaccinations for adults 50 years and older. As patients get older, their immune systems tend to weaken over time, putting them at higher risk of various diseases. Pharmacists play a key role in ensuring that the appropriate vaccines are used safely and effectively to help patients ensure proper immunization status based on current practice/literature. We will be discussing the evidence that leads to current recommendations of immunizations ... |
|
|
10-Night Peru CME AWAY™ Land Tour - Mood Disorders, ADD, COPD, Hypertension, VTE, Lyme Disease & High Altitude Illness
Lima, Peru ● Cusco, Peru ● Aguas Calientes, Peru ● Puno, Peru |
|
|
9-Night Kenya CME AWAY™ Land Tour - Cardiology, Diabetes, Mental Health, Obesity & Breast Cancer
Nairobi • Maasai Mara • Bogani Cottages & Tented Camp |
|